Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 33 Issue 1, January 2015

Scanning electron microscope image of an inorganic scaffold that can be used to boost vaccine efficacy (p 64; p 44) Credit: Aileen Li, Jaeyun Kim and James C Weaver

Editorial

  • Despite recent progress, only a fraction of the drug industry's shelved compounds are shared with the research community. Could online collaborative research offer a solution?

    Nature Outlook:

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

News Feature

  • The drug industry is struggling to find ways of engaging with consumers on social media. Failure to adapt may bring substantial opportunity costs, argues Virginia Hughes.

    • Virginia Hughes
    News Feature
Top of page ⤴

Bioentrepreneur

Top of page ⤴

Correspondence

Top of page ⤴

Feature

  • A new generation of commercial entities is beginning to explore opportunities for new types of interventions and services in a graying world.

    • Christopher Thomas Scott
    • Laura DeFrancesco
    Feature
Top of page ⤴

Patents

Top of page ⤴

News & Views

Top of page ⤴

Analysis

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Careers and Recruitment

  • As the biotech industry grows and shifts within an increasingly global economy, so does its need for talent that spans discovery through commercialization.

    • Kathy L Nugent
    • Lori Lindburg
    Careers and Recruitment
  • Careers and Recruitment
Top of page ⤴

Search

Quick links